MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-04-2026
Viemed Healthcare DPO Ratio 2011-2026 | VMD
Annual DPO Ratio Viemed Healthcare
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.1 | 19 | 17.7 | 19.8 | 22.3 | 23.9 | 86.1 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 86.1 | 17.7 | 29.9 |
Quarterly DPO Ratio Viemed Healthcare
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.3 | 28.1 | 23.4 | - | 23.8 | 25.1 | 21.9 | - | 29.4 | 27.7 | 20.3 | - | 12.1 | 13.1 | 25.3 | - | 30.1 | 23.3 | 19.8 | - | 13.7 | 11.3 | 37.6 | - | 67.9 | 75.4 | 95.8 | 111 | 131 | 94.5 | 35.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 131 | 11.3 | 40.9 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
33.7 | $ 186.84 | 3.42 % | $ 14 B |  USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
34.4 | $ 34.25 | 2.33 % | $ 1.58 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 12.72 | 3.21 % | $ 1.72 B | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 292.65 | 1.55 % | $ 8.26 B | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.59 | 1.2 % | $ 36.7 M | USA |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.04 | 0.59 % | $ 17.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.24 | -2.56 % | $ 121 M |  France |
 |
Bruker Corporation
BRKR
|
46.4 | $ 40.19 | 2.92 % | $ 5.99 K | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 64.09 | 1.44 % | $ 94.9 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
LENSAR
LNSR
|
146 | $ 6.07 | 2.45 % | $ 72.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 10.32 | 3.1 % | $ 292 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 25.32 | 1.48 % | $ 214 M | USA |
 |
Myomo
MYO
|
34.8 | $ 0.78 | 6.19 % | $ 32.6 M | USA |
 |
Inogen
INGN
|
34.6 | $ 6.42 | -0.54 % | $ 171 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Sintx Technologies
SINT
|
223 | $ 2.88 | 0.17 % | $ 7.99 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
33.1 | $ 95.81 | 3.04 % | $ 13 B | USA |
 |
Stryker Corporation
SYK
|
70.1 | $ 349.15 | 0.55 % | $ 133 B | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.0 | -1.48 % | $ 1.22 M | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.43 | 3.62 % | $ 938 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Tactile Systems Technology
TCMD
|
24.4 | $ 24.7 | 1.88 % | $ 565 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
TransMedics Group
TMDX
|
15.5 | $ 115.77 | 2.13 % | $ 3.94 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 17.72 | 4.54 % | $ 416 M | USA |
 |
Tandem Diabetes Care
TNDM
|
35.7 | $ 20.64 | 2.69 % | $ 1.4 B | USA |
 |
Delcath Systems
DCTH
|
56 | $ 10.78 | 3.16 % | $ 386 M | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 56.6 | 3.06 % | $ 1.66 B | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 39.46 | 2.6 % | $ 1.22 B | USA |